NBE-Therapeutics

NBE-Therapeutics

Pre-clinical
Basel, SwitzerlandFounded 2012nbe-therapeutics.com

At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody-drug conjugate platform targeting solid tumors.Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has b...

Founded
2012
Focus
AntibodiesBiologicsSmall Molecules

About

At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody-drug conjugate platform targeting solid tumors.Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has b...

Funding History

2

Total raised: $78M

Series B$45MPPF GroupJun 15, 2020
Series A$33MPPF GroupJan 15, 2018

Company Info

TypePrivate
Founded2012
LocationBasel, Switzerland
StagePre-clinical
SIMILAR COMPANIES
3Brain
3Brain
Pre-clinical · Zug
Baxiva
Baxiva
Pre-clinical · Zug
AC Bioscience
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
AdipoGen
Pre-clinical · Liestal
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile